Clearside Biomedical, Inc. (CLSD) quarterly income statement — complete revenue, gross profit & net income history
| Sales/Revenue | 201K | 492K | 2.33M | 306K | 1.04M | 90K | 230K | 6.34M | 859K | 1.02M | 4K | 330K |
| Revenue Growth % | -80.64% | 446.67% | 913.04% | -95.18% | 20.84% | -91.16% | 5650% | 1822.73% | 222.93% | 165.1% | -98.85% | -98.72% |
| Cost of Goods Sold | 0 | 84K | 248K | 149K | 0 | 0 | 28K | 20K | 142K | 213K | 0 | 226K |
| COGS % of Revenue | - | 17.07% | 10.64% | 48.69% | - | - | 12.17% | 0.32% | 16.53% | 20.92% | - | 68.48% |
| Gross Profit | 201K | 408K | 2.08M | 157K | 1.04M | 90K | 202K | 6.33M | 717K | 805K | 4K | 104K |
| Gross Margin % | 100% | 82.93% | 89.36% | 51.31% | 100% | 100% | 87.83% | 99.68% | 83.47% | 79.08% | 100% | 31.52% |
| Gross Profit Growth % | -80.64% | 353.33% | 930.69% | -97.52% | 44.77% | -88.82% | 4950% | 5981.73% | 169.55% | 132.66% | -98.85% | -99.59% |
| Operating Expenses | 7.24M | 3.98M | 7.29M | 7.31M | 6.97M | 7.68M | 8.41M | 9.24M | 7.77M | 8.07M | 7.61M | 8.17M |
| OpEx % of Revenue | 3602.49% | 808.13% | 312.75% | 2387.58% | 671.68% | 8533.33% | 3656.96% | 145.63% | 904.66% | 793.22% | 190225% | 2476.97% |
| Selling, General & Admin | 4.31M | 2.48M | 2.82M | 3.06M | 2.84M | 3.08M | 2.82M | 2.95M | 2.64M | 3.13M | 3.16M | 3.17M |
| SG&A % of Revenue | 2143.28% | 503.25% | 121.2% | 1000.65% | 273.99% | 3418.89% | 1227.83% | 46.45% | 306.98% | 307.17% | 78950% | 960.3% |
| Research & Development | 2.93M | 1.58M | 4.46M | 4.24M | 4.13M | 4.6M | 5.59M | 6.29M | 5.13M | 4.95M | 4.45M | 5M |
| R&D % of Revenue | 1459.2% | 321.95% | 191.55% | 1386.93% | 397.69% | 5114.44% | 2429.13% | 99.18% | 597.67% | 486.05% | 111275% | 1516.67% |
| Other Operating Expenses | 0 | -84K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -7.04M | -3.57M | -5.21M | -7.15M | -5.93M | -7.59M | -8.21M | -2.92M | -7.05M | -7.27M | -7.61M | -8.07M |
| Operating Margin % | -3502.49% | -725.2% | -223.39% | -2336.27% | -571.68% | -8433.33% | -3569.13% | -45.94% | -821.19% | -714.15% | -190125% | -2445.45% |
| Operating Income Growth % | -18.64% | 52.99% | 36.59% | -145.25% | 15.88% | -4.4% | -7.94% | 63.88% | -4.91% | 7.23% | 0.54% | -143.14% |
| EBITDA | -6.96M | -3.48M | -5.12M | -7.07M | -5.86M | -7.55M | -8.18M | -2.9M | -7.04M | -7.25M | -7.59M | -8.05M |
| EBITDA Margin % | -3460.7% | -708.13% | -219.74% | -2310.46% | -564.45% | -8384.44% | -3556.96% | -45.63% | -819.32% | -712.57% | -189750% | -2438.79% |
| EBITDA Growth % | -18.72% | 53.83% | 37.42% | -144.21% | 16.75% | -4.03% | -7.79% | 64.03% | -5.28% | 6.99% | 0.13% | -142.92% |
| D&A (Non-Cash Add-back) | 84K | 84K | 85K | 79K | 75K | 44K | 28K | 20K | 16K | 16K | 15K | 22K |
| EBIT | -3.4M | -1.73M | -4.83M | -4.73M | -5.23M | -5.25M | -9.36M | -2.56M | -6.64M | -6.81M | -7.11M | -7.62M |
| Net Interest Income | -2.5M | -2.65M | -2.51M | -2.22M | -2.12M | -1.92M | -2.06M | -2.28M | -2.21M | -1.84M | -1.68M | -2.04M |
| Interest Income | 65K | 115K | 163K | 358K | 338K | 419K | 348K | 0 | 409K | 458K | 492K | 0 |
| Interest Expense | 2.57M | 2.76M | 2.67M | 2.58M | 2.46M | 2.34M | 2.4M | 2.28M | 2.62M | 2.29M | 2.17M | 2.04M |
| Other Income/Expense | 1.07M | -927K | -2.3M | -157K | -1.75M | -4K | -3.55M | -1.92M | -2.21M | -1.84M | -1.68M | -1.59M |
| Pretax Income | -5.97M | -4.5M | -7.51M | -7.31M | -7.69M | -7.59M | -11.76M | -4.83M | -9.27M | -9.11M | -9.28M | -9.66M |
| Pretax Margin % | -2971.14% | -913.62% | -322.23% | -2387.58% | -740.66% | -8437.78% | -5114.35% | -76.15% | -1078.81% | -894.5% | -232000% | -2928.18% |
| Income Tax | 0 | 0 | 715K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | -9.52% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -5.97M | -4.5M | -8.22M | -7.31M | -7.69M | -7.59M | -11.76M | -4.83M | -9.27M | -9.11M | -9.28M | -9.66M |
| Net Margin % | -2971.14% | -913.62% | -352.92% | -2387.58% | -740.66% | -8437.78% | -5114.35% | -76.15% | -1078.81% | -894.5% | -232000% | -2928.18% |
| Net Income Growth % | 22.32% | 40.81% | 30.09% | -51.2% | 17.04% | 16.6% | -26.76% | 49.99% | -18.4% | -16.55% | -21.43% | -151.65% |
| Net Income (Continuing) | -5.97M | -4.5M | -8.22M | -7.31M | -7.69M | -7.59M | -11.76M | -4.83M | -9.27M | -9.11M | -9.28M | -9.66M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -1.14 | -0.87 | -1.65 | -1.44 | -1.50 | -1.50 | -2.55 | -1.16 | -2.25 | -2.25 | -2.25 | -2.10 |
| EPS Growth % | 24% | 42% | 35.29% | -24.42% | 33.33% | 33.33% | -13.33% | 44.71% | -15.38% | -15.38% | -15.38% | -145.16% |
| EPS (Basic) | -1.14 | -0.87 | -1.65 | -1.44 | -1.50 | -1.50 | -2.55 | -1.16 | -2.25 | -2.25 | -2.25 | -2.10 |
| Diluted Shares Outstanding | 5.23M | 5.19M | 5.13M | 5.06M | 4.98M | 4.98M | 4.66M | 4.16M | 4.13M | 4.11M | 4.08M | 4.03M |
| Basic Shares Outstanding | 5.23M | 5.19M | 5.13M | 5.06M | 4.98M | 4.98M | 4.66M | 4.16M | 4.13M | 4.11M | 4.08M | 4.03M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - |